The Pennant Group Third Quarter 2026 Earnings Call - PENNANT GROUP INC

Explicit Guidance:

• Management reaffirmed full-year 2026 guidance expectations, citing that underlying operations remain consistent with projections despite elevated benefits costs.
• Q4 2026 earnings projections have been adjusted to include anticipated elevated employee benefits expenses (estimated at approximately 50 basis points of revenue), which are built into the financial model due to typical year-end benefit utilization trends.
• Revenue per episode declines in new Southeast home health locations due to lower wage indices are expected to persist, though managed care contract transitions and quality metrics are projected to drive rate renegotiations long-term.

Business-Segment Outlook:

• Home Health & Hospice: Expect continued strong same-store performance and growth; total home health admissions grew 39.4% YoY in Q3. The integration of UnitedHealth and Amedisys assets in the Southeast is nearly complete (EMR transition finished Oct 31), with a focus shifting to optimization and closing the performance gap with traditional same-store operations over the next couple of years.
• Senior Living: Expects Q4 2026 to be a "step in the right direction" regarding occupancy recovery, with a targeted bounce-back expected in the two specific markets experiencing transition-related lumps. Long-term outlook anticipates significant growth over a 9-quarter optimization period for newly acquired communities, with some distressed assets potentially recovering faster if occupancy is already present.
• Leadership Development: Pipeline includes 30+ "CEOs in Training" (CITs) graduated from the senior living program this year, with robust capacity to backfill leadership roles and support future acquisitions without significant organizational strain.

Market and Competitive Outlook:

• Home Health Rates: Anticipates long-term upside in managed care contract rates as payers narrow networks to high-quality providers; Pennant positions itself as a top-tier partner due to superior clinical outcomes (e.g., lower preventable hospitalization rates, 5-star ratings) compared to industry averages.
• Competitive Positioning: Sees structural opportunity in converting lower-quality providers into high-quality partnerships as payers utilize "gold carding" and network reduction strategies.
• Senior Living Occupancy: Recent declines attributed to concentration in two markets during integration; expects this to normalize as local operators regain bandwidth and focus on filling low-occupancy acquisitions acquired at discounts.

Macro / Industry Outlook:

• Regulatory Impact (Home Health): The final CMS rule introduces a 2.1% net rate increase (1.5% effective for claim-based pricing), viewed as insufficient given high inflation but a positive step; supports bills in Congress to address underfunding.
• Program Integrity: Acknowledges new CMS program integrity measures targeting fraud but notes concerns over overly broad burdens on legitimate providers; management is prepared to adapt.
• Benefits Volatility: Anticipates elevated employee benefits costs as a structural headwind for Q4, driven by self-funded plan dynamics affecting the entire portfolio, not just acquired units.

Strategic Initiatives:

• M&A (Real Estate): Completed acquisition of real estate for Main Place Senior Living in Orange, CA, to capture value from operational turnaround and ensure long-term stability; acquired River Center in Tucson, AZ, to deepen cluster density despite short-term financial drag from low occupancy.
• Integration: Finalized EMR, branding, and leadership transitions for the UnitedHealth/Amedisys assets; focus shifting from integration to optimization and revenue per episode improvement.
• Expansion: Plans to prioritize stabilization and optimization of 2026 senior living acquisitions in the near term, with potential for selective, non-disruptive M&A in well-performing markets.
• Capacity: Continued heavy investment in infrastructure and leadership training to support larger acquisition volumes and internal promotion of C-level leaders.

Risks and Headwinds to Outlook:

• Integration Lumpy-ness: Short-term operational volatility and margin pressure expected during the integration of high-growth acquisitions, particularly where growth outpaced leadership capacity in specific markets.
• Benefit Cost Volatility: Elevated employee benefits costs could remain a variable affecting margins in Q4 and beyond if year-end utilization trends exceed projections.
• Regulatory Burden: Potential for new CMS program integrity measures to impose administrative burdens on legitimate providers.
• Payer Rate Pressures: Continued revenue per episode pressure in newly acquired geographies (Southeast) due to wage index disparities until managed care contracts can be renegotiated.
• Leadership Bandwidth: Transitions of large portfolios (e.g., 50% of UnitedMedics assets integrated in 120 days) create temporary bandwidth challenges for existing operators, potentially delaying full performance realization in specific markets.

Management Tone on the Future:

• Confidence: High confidence in achieving full-year guidance and long-term value creation, characterized by a "long-term perspective" rather than short-term result focus.
• Outlook: Described as "tremendous positive momentum" with a "dynamic flywheel" effect from internal leadership development.
• Hedges: Explicitly noted that senior living results may remain "lumpy" in the short term during transitions, particularly for acquisitions with low occupancy and significant distress, but emphasized a clear path to long-term upside.
• Change vs. Prior: No changes to full-year guidance; integration progress is "ahead of initial projections," though Q4 benefits costs are acknowledged as an elevated factor.

Miscellaneous:

• Operational Metrics: Same-store margin increased 80 bps YoY in Home Health; same-store admissions up 8%, Medicare admissions up 12%, and revenue per episode up 1.6% in the segment.
• Clinical Outperformance: Potentially preventable hospitalization rate at 9.9% (vs. 10.8% industry average); Hospice Quality Composite score at 98.3% (vs. 96.2% industry average).
• Financial Health: Cash on hand $18.4 million; $103 million outstanding on line of credit; Net debt to Adjusted EBITDA at 1.95x.
• Acquisition Strategy: Opportunistic approach targets low-occupancy assets acquired at substantial discounts to market rates, prioritizing mid- to long-term upside over immediate short-term financial drag.